Détail - canceropole-wordpress

Up-to-Date Imaging for Parathyroid Tumor Localization in MEN1 Patients with Primary Hyperparathyroidism: When and Which Ones (A Narrative Pictorial Review).

Berti V, Mungai F, Lucibello P, Brandi ML, Biagini C, Imperiale A

Diagnostics (Basel). 2024 12 25;15(1):

Organ-specific response to [Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumors.

Mamulashvili Bessac D, Baltzinger P, Poterszman N, Pham Van F, Collen C, Malouf GG, Ouvrard E, Kaseb A, Porot C, Ben Abdelghani M, Addeo P, Mertz L, Goichot B, Imperiale A

Endocrine. 2024 12 23;:

Deciphering F-DOPA uptake in SDH-related head and neck paragangliomas: a radiomics approach.

Berti V, Fasciglione E, Charpiot A, Montanini F, Pepponi M, Leo A, Hubele F, Taieb D, Pacak K, Goichot B, Imperiale A

J Endocrinol Invest. 2024 12 12;:

Detection of cardiac neuroendocrine tumour metastases by somatostatin receptor PET/CT: a systematic review and meta-analysis.

Campanale D, Imperiale A, Albano D, Rizzo A, Piccardo A, Treglia G

Front Med (Lausanne). 2024 10 15;11:1491181

Refining the role of presurgical PET/4D-CT in a large series of patients with primary hyperparathyroidism undergoing [F]Fluorocholine PET/CT.

Kaseb A, Benider H, Treglia G, Cusumano C, Bessac D, Trimboli P, Vix M, Piccardo A, Latgé A, Imperiale A

Eur J Clin Invest. 2024 10 12;:e14336

SDH-related head and neck paragangliomas: Unraveling PET radiomics beyond F-FDG.

Imperiale A, Berti V

Best Pract Res Clin Endocrinol Metab. 2024 08 23;:101926

Polymyalgia Rheumatica During the Course of Limited Cutaneous Scleroderma: An Unusual and Challenging Coexistence.

Lorenzo-Villalba N, Habib C, Docquier L, Nasco E, Imperiale A, Andrès E, Terrade JE

Eur J Case Rep Intern Med. 2024 07 1;11(7):004709

Further explanations about the role of thyroid scintigraphy in the era of TIRADS.

Trimboli P, Bojunga J, Deandrea M, Frasca F, Imperiale A, Leoncini A, Paone G, Pitoia F, Rotondi M, Sadeghi R, Scappaticcio L, Treglia G, Piccardo A

Endocrine. 2024 06 20;:

[F]Fluorocholine PET/CT as First-Line vs. Second-Line Imaging Method to localize parathyroid adenomas in primary hyperparathyroidism: "Game, Set, and Match".

Treglia G, Piccardo A, Paone G, Trimboli P, Imperiale A

Eur J Nucl Med Mol Imaging. 2024 05 29;:

Inflammation and Myocardial Blood Flow in Cardiac Sarcoidosis.

Parihar AS, Valenta I, Mikhail S, Imperiale A, Schindler TH

Curr Cardiol Rep. 2024 05 22;:

A bicentric retrospective study of the correlation of EAU BCR risk groups with F-PSMA-1007 PET/CT detection in prostate cancer biochemical recurrence.

Poterszman N, Merlin C, Margail C, Ouvrard E, Imperiale A, Somme F

Sci Rep. 2024 05 13;14(1):10908

[Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation.

Pepponi M, Berti V, Fasciglione E, Montanini F, Canu L, Hubele F, Abenavoli E, Briganti V, Rapizzi E, Charpiot A, Taieb D, Pacak K, Goichot B, Imperiale A

Eur J Nucl Med Mol Imaging. 2024 04 30;:

Reappraising the role of thyroid scintigraphy in the era of TIRADS: A clinically-oriented viewpoint.

Trimboli P, Bojunga J, Deandrea M, Frasca F, Imperiale A, Leoncini A, Paone G, Pitoia F, Rotondi M, Sadeghi R, Scappaticcio L, Treglia G, Piccardo A

Endocrine. 2024 04 16;:

Taming the tiger: Insights into sarcoid myositis through 18F-FDG PET/MRI imaging.

Kaseb A, Giannini M, Dramé B, Willaume T, Meyer A, Imperiale A

QJM. 2024 04 12;:

Recurrent non-rheumatic streptococcal myocarditis: 18F-FDG PET/CMR findings.

Baltzinger P, El Ghannudi S, Germaini M, Von Hunolstein JJ, Zeyons F, Imperiale A

QJM. 2024 01 25;:

Nuclear medicine imaging for bone metastases assessment: what else besides bone scintigraphy in the era of personalized medicine?

Ouvrard E, Kaseb A, Poterszman N, Porot C, Somme F, Imperiale A

Front Med (Lausanne). 2024 01 15;10:1320574

Preoperative F-FDG PET/CT in Patients with Presumed Localized Colon Cancer: A Prospective Study with Long-Term Follow-Up.

Aymard S, Rust E, Kaseb A, Liu D, Hubele F, Romain B, Averous G, Brigand C, Imperiale A

Cancers (Basel). 2024 01 4;16(1):

Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement.

Taïeb D, Nölting S, Perrier ND, Fassnacht M, Carrasquillo JA, Grossman AB, Clifton-Bligh R, Wanna GB, Schwam ZG, Amar L, Bourdeau I, Casey RT, Crona J, Deal CL, Del Rivero J, Duh QY, Eisenhofer G, Fojo T, Ghayee HK, Gimenez-Roqueplo AP, Gill AJ, Hicks R, Imperiale A, Jha A, Kerstens MN, de Krijger RR, Lacroix A, Lazurova I, Lin FI, Lussey-Lepoutre C, Maher ER, Mete O, Naruse M, Nilubol N, Robledo M, Sebag F, Shah NS, Tanabe A, Thompson GB, Timmers HJLM, Widimsky J, Young WJ, Meuter L, Lenders JWM, Pacak K

Nat Rev Endocrinol. 2023 12 14;:

Performance of [F]fluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent disease.

Boucher A, Delabie J, Lussey-Lepoutre C, Haissaguerre M, Ouvrard E, Lavinia V, Le Bras M, Batisse-Lignier M, Cuny T, Jacquet-Francillon N, Gaujoux S, Molina O, Imperiale A, Latge A, Ansquer C, Kelly A, Borson-Chazot F, Tlili G, Sebag F, Hamidou Z, Romanet P, Taïeb D

Eur J Nucl Med Mol Imaging. 2023 12 7;:

18F-FDG PET/MRI for Diagnosis and Treatment Efficacy Evaluation of Spinal Sarcoidosis.

Kaseb A, Bessac D, Frantzen L, Herber M, Poindron V, Imperiale A

Clin Nucl Med. 2023 12 1;:

A radiomic- and dosiomic-based machine learning regression model for pretreatment planning in Lu-DOTATATE therapy.

Plachouris D, Eleftheriadis V, Nanos T, Papathanasiou N, Sarrut D, Papadimitroulas P, Savvidis G, Vergnaud L, Salvadori J, Imperiale A, Visvikis D, Hazle JD, Kagadis GC

Med Phys. 2023 09 18;:

Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities.

Imperiale A, Berti V, Burgy M, Cazzato RL, Piccardo A, Treglia G

Rev Endocr Metab Disord. 2023 09 16;:

High Tumor Uptake on F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network.

De Rycke O, Perrier M, Ouvrard É, Mennetrey C, Lachachi C, Bando-Delaunay A, Morland D, Goichot B, Taieb D, Walter T, Cadiot G, Cros J, Hentic O, Ruszniewski P, Lebtahi R, Imperiale A, de Mestier L

J Nucl Med. 2023 08 31;:

Pancreatic metastasis from small bowel neuroendocrine tumor.

Addeo P, Fattori A, Imperiale A, Bachellier P

Dig Liver Dis. 2023 07 21;:

Tales from the future - Nuclear cardio-oncology, from prediction to diagnosis and monitoring.

Mikail N, Chequer R, Imperiale A, Meisel A, Bengs S, Portmann A, Gimelli A, Buechel RR, Gebhard C, Rossi A

Eur Heart J Cardiovasc Imaging. 2023 07 19;:

Impact of Cold Somatostatin Analog Administration on Somatostatin Receptor Imaging: A Systematic Review.

Morland D, Laures N, Triumbari EKA, Perrier M, Imperiale A, Annunziata S, Rufini V

Clin Nucl Med. 2023 06 1;48(6):467-473

[18F]F-Choline PET/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies?

Fiz F, Bottoni G, Massollo M, Trimboli P, Catrambone U, Bacigalupo L, Righi S, Treglia G, Imperiale A, Piccardo A

Q J Nucl Med Mol Imaging. 2023 06;67(2):130-137

Molecular imaging phenotyping of germline fumarate hydratase (FH) pathogenic variant-positive metastatic pheochromocytoma.

Imperiale A, Pepponi M, Poterszman N, Jha A, Collen C, Brumaru D, Chenard MP, Taïeb D, Pacak K, Goichot B

Eur J Nucl Med Mol Imaging. 2023 05 9;:

Does F-Fluorocholine PET/CT add value to positive parathyroid scintigraphy in the presurgical assessment of primary hyperparathyroidism?

Imperiale A, Bani J, Bottoni G, Latgé A, Heimburger C, Catrambone U, Vix M, Treglia G, Piccardo A

Front Med (Lausanne). 2023 04 27;10:1148287

18F-FDG primary tumor uptake to improve N status prediction in cT1 non-metastatic non-small cell lung cancer: development and validation of a positron emission tomography model.

Morland D, Chiappetta M, Falcoz PE, Chenard MP, Annunziata S, Boldrini L, Lococo F, Imperiale A

Front Med (Lausanne). 2023 04 26;10:1141636

F-Fluorocholine PET/CT Compared with Current Imaging Procedures for Preoperative Localization of Hyperfunctioning Parathyroids in Patients with Chronic Kidney Disease.

Aymard S, Leroy-Freschini B, Kaseb A, Marx D, Helali M, Averous G, Betz V, Riehm S, Vix M, Perrin P, Imperiale A

Diagnostics (Basel). 2023 04 8;13(8):

Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.

Taïeb D, Wanna GB, Ahmad M, Lussey-Lepoutre C, Perrier ND, Nölting S, Amar L, Timmers HJLM, Schwam ZG, Estrera AL, Lim M, Pollom EL, Vitzthum L, Bourdeau I, Casey RT, Castinetti F, Clifton-Bligh R, Corssmit EPM, de Krijger RR, Del Rivero J, Eisenhofer G, Ghayee HK, Gimenez-Roqueplo AP, Grossman A, Imperiale A, Jansen JC, Jha A, Kerstens MN, Kunst HPM, Liu JK, Maher ER, Marchioni D, Mercado-Asis LB, Mete O, Naruse M, Nilubol N, Pandit-Taskar N, Sebag F, Tanabe A, Widimsky J, Meuter L, Lenders JWM, Pacak K

Lancet Diabetes Endocrinol. 2023 03 31;:

The emergence of somatostatin antagonist-based theranostics: Paving the road toward another success?

Imperiale A, Jha A, Meuter L, Nicolas GP, Taïeb D, Pacak K

J Nucl Med. 2023 02 9;:

Hyperfunctioning Intrathyroidal Parathyroid: a Misleading Preoperative Diagnosis.

Carullo J, Bani J, Averous G, Helali M, Heimburger C, Vix M, Imperiale A

Nucl Med Mol Imaging. 2023 02;57(1):46-50

Update on Management of Medullary Thyroid Carcinoma: Focus on Nuclear Medicine.

Treglia G, Rufini V, Piccardo A, Imperiale A

Semin Nucl Med. 2023 01 24;:

Neuroendocrine Tumors: Treatment and Management.

Imperiale A

Cancers (Basel). 2022 08 22;14(16):

Imaging of heart disease in women: review and case presentation.

Mikail N, Rossi A, Bengs S, Haider A, Stähli BE, Portmann A, Imperiale A, Treyer V, Meisel A, Pazhenkottil AP, Messerli M, Regitz-Zagrosek V, Kaufmann PA, Buechel RR, Gebhard C

Eur J Nucl Med Mol Imaging. 2022 08 17;:

CuCl PET Imaging of 4T1-Related Allograft of Triple-Negative Breast Cancer in Mice.

Latgé A, Boisson F, Ouadi A, Averous G, Thomas L, Imperiale A, Brasse D

Molecules. 2022 07 29;27(15):

177Lu-DOTA-0-Tyr3-octreotate infusion modeling for real-time detection and characterization of extravasation during PRRT.

Mazzara C, Salvadori J, Ritzenthaler F, Martin S, Porot C, Imperiale A

EJNMMI Phys. 2022 May 3;9(1):33

Molecular imaging of endocrine neoplasms with emphasis on 18F-DOPA PET: a practical approach for well-tailored imaging protocols.

Fargette C, Imperiale A, Taïeb D

Q J Nucl Med Mol Imaging. 2022 Mar 28;:

Parathyromatosis: a challenging cause of recurrent primary hyperparathyroidism.

Latgé A, Averous G, Helali M, Bachellier P, Imperiale A

QJM. 2022 Feb 15;:

Simultaneous Resection of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases: Safety and Oncological Efficacy.

Addeo P, Cusumano C, Goichot B, Guerra M, Faitot F, Imperiale A, Bachellier P

Cancers (Basel). 2022 Jan 30;14(3):

Value of somatostatin receptor PET/CT in MEN1 patients at various stages of their disease.

Mennetrey C, Le Bras M, Bando-Delaunay A, Al-Mansour L, Haissaguerre M, Batisse-Lignier M, Ouvrard E, Ansquer C, Walter T, de Mestier L, Kelly A, Tlili G, Giraud S, North MO, Odou MF, Goichot B, Cuny T, Loundou A, Romanet P, Imperiale A, Taïeb D

J Clin Endocrinol Metab. 2021 Dec 23;:

Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures.

Cazzato RL, Hubelé F, De Marini P, Ouvrard E, Salvadori J, Addeo P, Garnon J, Kurtz JE, Greget M, Mertz L, Goichot B, Gangi A, Imperiale A

Cancers (Basel). 2021 Dec 19;13(24):

F-Fluorocholine PET and 4D-CT in Patients with Persistent and Recurrent Primary Hyperparathyroidism.

Latge A, Riehm S, Vix M, Bani J, Ignat M, Pretet V, Helali M, Treglia G, Imperiale A

Diagnostics (Basel). 2021 Dec 17;11(12):

Identification and characterization of cardiac sarcoidosis with positron emission tomography.

Schindler TH, Anderson A, El Ghannudi S, Imperiale A

Eur J Clin Invest. 2021 Dec 5;:e13722

Should pituitary carcinoma be treated using a NET-like approach? A case of complete remission of a metastatic malignant prolactinoma with multimodal therapy including immunotherapy.

Goichot B, Taquet MC, Baltzinger P, Baloglu S, Gravaud M, Malouf GG, Noël G, Imperiale A

Clin Endocrinol (Oxf). 2021 Nov 29;:

Dual-Time-Point 18F-Fluorocholine PET/CT Improves Characterization of Thyroid Nodules in Patients Referred for Primary Hyperparathyroidism: A Proof of Concept Study.

Bani J, Morland D, Hubelé F, Ignat M, Latge A, Bourahla K, Zalzali M, Vix M, Taïeb D, Imperiale A

Clin Nucl Med. 2021 Sep 13;:

B Cell Lymphoma in an Intrapancreatic Accessory Spleen.

Kansoun A, Julliard O, Imperiale A, Bruetschy A, Bachellier P, Addeo P

J Gastrointest Surg. 2021 Sep 7;:

Impact of pelvic dynamic acquisition on final reading of F-Fluorocholine positron emission tomography in patients with prostate adenocarcinoma: True need or unnecessary burden?

Latge A, Heimburger C, Severac F, Meyer N, Somme F, Imperiale A

J Med Imaging Radiat Oncol. 2021 Jul 29;:

Values of Ga-DOTATOC and Carbidopa-assisted F-DOPA PET/CT for insulinoma localization.

Imperiale A, Boursier C, Sahakian N, Ouvrard E, Chevalier E, Sebag F, Addeo P, Taïeb D

J Nucl Med. 2021 Jul 16;:

Primary Hyperparathyroidism: Defining the Appropriate Preoperative Imaging Algorithm.

Hindié E, Schwartz P, Avram AM, Imperiale A, Sebag F, Taïeb D

J Nucl Med. 2021 Jul;62(Suppl 2):3S-12S

Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine Tumors.

Debien V, Davidson G, Baltzinger P, Kurtz JE, Séverac F, Imperiale A, Pessaux P, Addeo P, Bachellier P, Su X, Davidson I, Chenard MP, Goichot B, Malouf GG

Cancers (Basel). 2021 Jun 2;13(11):

Advantages of 18F-FDG PET/CT Imaging over Modified Duke Criteria and Clinical Presumption in Patients with Challenging Suspicion of Infective Endocarditis.

Pretet V, Blondet C, Ruch Y, Martinez M, Ghannudi SE, Morel O, Hansmann Y, Schindler TH, Imperiale A

Diagnostics (Basel). 2021 Apr 18;11(4):

Variants and Pitfalls of PET/CT in Neuroendocrine Tumors.

Imperiale A, Meuter L, Pacak K, Taïeb D

Semin Nucl Med. 2021 Apr 7;:

Imaging of small intestine neuroendocrine neoplasms: Is SSTR PET the holy grail?

Imperiale A, Meuter L, Pacak K, Taieb D

J Nucl Med. 2021 Mar 26;:

Original Preoperative Localization Technique of Parathyroid Adenomas by 3-Dimensional Virtual Neck Exploration.

Ignat M, Pérouse M, Lefebvre F, Kadoche D, Imperiale A, Swanstrom L, Vix M, Mutter D

Surg Innov. 2021 Mar 20;:15533506211001236

18F-FDG PET/CT Monitoring of Tumor Response to Tyrosine Kinase Inhibitors and Alkylating Drugs in an SDH-Deficient GIST.

Somme F, Bender L, Kurtz JE, Gantzer J, Imperiale A

Clin Nucl Med. 2021 Mar 16;:

Middle-segment preserving pancreatectomy for multifocal neuroendocrine pancreatic tumors.

Addeo P, Julliard O, Imperiale A, Goichot B, Bachellier P

Surg Oncol. 2020 Oct 14;35:466-467

Intra-individual comparison of F-FDOPA and Ga-DOTATOC PET/CT detection rate for metastatic assessment in patients with ileal neuroendocrine tumours.

Ouvrard E, Chevalier E, Addeo P, Sahakian N, Detour J, Goichot B, Bachellier P, Karcher G, Taïeb D, Imperiale A

Clin. Endocrinol. (Oxf). 2020 Aug 13;:

F-Florbetaben and PET/CT Holds Promise for the Identification and Differentiation Among Cardiac Amyloidosis Entities.

Schindler TH, Sharma V, Imperiale A

JACC Cardiovasc Imaging. 2020 Aug 3;:

F-Fluorocholine PET and Multiphase CT Integrated in Dual Modality PET/4D-CT for Preoperative Evaluation of Primary Hyperparathyroidism.

Pretet V, Rotania M, Helali M, Ignat M, Vix M, Imperiale A

J Clin Med. 2020 Jun 26;9(6):

68Ga-DOTATOC PET for Treatment Efficacy Evaluation of Cardiac Sarcoidosis.

Imperiale A, Poindron V, Martinez M, Ohlmann P, Schindler TH, El Ghannudi S

Clin Nucl Med. 2020 Jun 25;:

Laparoscopic resection of familial interaortocaval paraganglioma.

Addeo P, Julliard O, Imperiale A, Goichot B, Bachellier P

Surg Oncol. 2020 Jun;33:143-144

Tc-labelled bone tracer myocardial quantification: About correlation with heart function.

Blondet C, Schaeffer O, Hubelé F, Roul GJ, Imperiale A, Namer IJ

J Nucl Cardiol. 2020 May 13;:

Solid pseudopapillary tumor should be part of differential diagnosis of focal pancreatic lesions with increased F-FDOPA uptake.

Somme F, Montaz-Rosset MS, Averous G, Deur J, Goichot B, Bachellier P, Addeo P, Imperiale A

Clin. Endocrinol. (Oxf). 2020 Apr 20;:

Outcomes of Simultaneous Resection of Small Bowel Neuroendocrine Tumors with Synchronous Liver Metastases.

Addeo P, Bertin JB, Imperiale A, Averous G, Terrone A, Goichot B, Bachellier P

World J Surg. 2020 Mar 16;:

Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic Metastases.

Imperiale A, Poncet G, Addeo P, Ruhland E, Roche C, Battini S, Cicek AE, Chenard MP, Hervieu V, Goichot B, Bachellier P, Walter T, Namer IJ

Metabolites. 2019 Dec 11;9(12):

Prognostic and predictive value of nuclear imaging in endocrine oncology.

Treglia G, Goichot B, Giovanella L, Hindié E, Jha A, Pacak K, Taïeb D, Walter T, Imperiale A

Endocrine. 2019 Nov 16;:

PET/CMR: One More Step Toward Noninvasive Morphofunctional Diagnosis of Cardiac Malignancies.

El Ghannudi S, Germain P, Averous G, Gangi A, Schindler TH, Imperiale A

JACC Cardiovasc Imaging. 2019 Oct 11;:

Synchronous bilateral pheochromocytomas and bilobar medullary thyroid carcinoma revealed by F-FDOPA PET/CT in a MEN-2A asymptomatic patient.

Rotania M, Chabrier G, Imperiale A

Endocrine. 2019 Sep 2;:

Cardiac metastasis from medullary thyroid carcinoma: insights from multimodal molecular imaging and magnetic resonance imaging.

El Ghannudi S, Germain P, Schneegans O, Schindler TH, Imperiale A

Eur Heart J Cardiovasc Imaging. 2019 Aug 9;:

Limited role of carbidopa-assisted F-FDOPA PET/CT in patients with sporadic non-functional gastroduodenal neuroendocrine neoplasms.

Imperiale A, Averous G, Helali M, Taieb D, Pessaux P, Goichot B, Addeo P, Bachellier P

Ann Nucl Med. 2019 Jun 15;:

Cardiac Metastases of Small-Bowel Carcinoid.

El Ghannudi S, Ben Abdelghani M, Germain P, Blondet C, Romain B, Imperiale A

Circ Cardiovasc Imaging. 2019 Feb;12(2):e008405

F-FDOPA PET/CT Combined with MRI for Gross Tumor Volume Delineation in Patients with Skull Base Paraganglioma.

Helali M, Moreau M, Le Fèvre C, Heimburger C, Bund C, Goichot B, Veillon F, Hubelé F, Charpiot A, Noel G, Imperiale A

Cancers (Basel). 2019 Jan 8;11(1):

Early F-FDOPA PET/CT imaging after carbidopa premedication as a valuable diagnostic option in patients with insulinoma.

Leroy-Freschini B, Amodru V, Addeo P, Sebag F, Vix M, Brunaud L, Klein M, Bahougne T, Bachellier P, Castinetti F, Goichot B, Chevalier E, Taieb D, Imperiale A

Eur. J. Nucl. Med. Mol. Imaging. 2019 Jan 7;:

Macrovascular venous invasion of pancreatic neuroendocrine tumours: impact on surgical outcomes and survival.

Addeo P, d'Alessandro A, Averous G, Imperiale A, Faitot F, Goichot B, Bachellier P

HPB (Oxford). 2018 Dec 3;:

18F-FDOPA Uptake Reflects the Efficacy of Dopamine Agonists Treatment in Pituitary Prolactinoma.

Heimburger C, Bund C, Addeo P, Goichot B, Imperiale A

Clin Nucl Med. 2018 Sep;43(9):e324-e325

Imaging sphenoid diseases.

Braun JJ, Debry C, Imperiale A, Riehm S

Clin Radiol. 2018 Sep;73(9):761-772

Role of positron emission tomography in thyroid and neuroendocrine tumors.

Treglia G, Kroiss AS, Piccardo A, Lococo F, Santhanam P, Imperiale A

Minerva Endocrinol.. 2018 Sep;43(3):341-355

Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis.

Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, Giovanella L

Eur. J. Nucl. Med. Mol. Imaging. 2018 Aug 9;:

F-Fluorocholine PET/CT as a second line nuclear imaging technique before surgery for primary hyperparathyroidism.

Imperiale A, Taïeb D, Hindié E

Eur. J. Nucl. Med. Mol. Imaging. 2018 04;45(4):654-657

Aortitis: A new feature of Schnitzler syndrome.

Bursztejn AC, Imperiale A, Lipsker D

JAAD Case Rep. 2017 Sep;3(5):454-456

Implications of SDHB genetic testing in patients with sporadic pheochromocytoma.

Maignan A, Guerin C, Julliard V, Paladino NC, Kim E, Roche P, Castinetti F, Essamet W, Mancini J, Imperiale A, Clifton-Bligh R, Romanet P, Barlier A, Pacak K, Sebag F, Taïeb D

Langenbecks Arch Surg. 2017 Aug;402(5):787-798